An in-situ forming implant formulation of naltrexone with minimum initial burst release using mixture of PLGA copolymers and ethyl heptanoate as an additive: In-vitro, ex-vivo, and in-vivo release evaluation-Reference-Cited by-同舟云学术

An in-situ forming implant formulation of naltrexone with minimum initial burst release using mixture of PLGA copolymers and ethyl heptanoate as an additive: In-vitro, ex-vivo, and in-vivo release evaluation

Published:2018-10 Issue: Volume:47 Page:95-105
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Kamali Hossein,Khodaverdi Elham,Hadizadeh Farzin,Yazdian-Robati Rezvan,Haghbin Ali,Zohuri Golamhossein

Funder

Research Council of Mashhad University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference56 articles.

1. Sustained-release naltrexone: novel treatment for opioid dependence;Comer;Expet Opin. Invest. Drugs,2007

2. Blood naltrexone levels over time following naltrexone implant;Ngo;Prog. Neuro-Psychopharmacol. Biol. Psychiatry,2008

3. Histological changes over time around the site of sustained release naltrexone-poly (DL-lactide) implants in humans;Hulse;J. Contr. Release,2005

4. Open label trial of naltrexone implants: measuring blood serum levels of naltrexone;Colquhoun;Subst. Abuse Res. Treat.,2013

5. A ‘biorelevant’system to investigate in vitro drug released from a naltrexone implant;Iyer;Int. J. Pharm.,2007

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular docking, molecular dynamics simulation, preparation, and characterization of naltrexone-phospholipid complex: A novel cargo with improved loading into multivesicular liposomes;Results in Chemistry;2024-07

2. In-situ forming biodegradable implants for sustained Fluocinolone acetonide release to the posterior eye: In-vitro and in-vivo investigations in rabbits;International Journal of Pharmaceutics;2024-04

3. Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes;Journal of Drug Delivery Science and Technology;2024-03

4. Design of an injectable sustained release in-situ forming depot of meloxicam for pain relief;Journal of Drug Delivery Science and Technology;2024-03

5. Design and in vitro characterization of in situ forming prolonged release implant formulations of a narcotic antagonist drug;Macedonian Pharmaceutical Bulletin;2023-09